Literature DB >> 20407305

At home and on demand mechanical cough assistance program for patients with amyotrophic lateral sclerosis.

Michele Vitacca1, Mara Paneroni, Debora Trainini, Luca Bianchi, Giuliano Assoni, Manuela Saleri, Sonia Gilè, João C Winck, Miguel R Gonçalves.   

Abstract

OBJECTIVE: To establish a cost-effective telephone-accessed consultation and mechanical in-exsufflation (MI-E) and manually assisted coughing, oximetry feedback program for 39 patients with amyotrophic lateral sclerosis.
DESIGN: Rapid access to healthcare consultation and to MI-E was provided to treat episodes of distress as a result of secretion encumbrance not reversed by suctioning and associated with a decrease in oxyhemoglobin saturation (SpO(2)) baseline. Avoided hospitalizations, defined by relief of respiratory distress and return of SpO(2) baseline to >or=95% by continuous ventilator use and assisted coughing, were recorded. Patient satisfaction was queried at 6 mos, and a cost analysis was performed of continuous vs. on demand MI-E use.
RESULTS: Thirty-nine patients made a total of 1661 calls in 7.46 +/- 5.8 mos of follow-up. Twenty-seven patients had 66 home care visits by a respiratory therapist for a total time commitment of 89.7 +/- 99.3 min/patient/mo. Twelve patients, all ventilator users, were also brought mechanical in-exsufflators for mechanically assisted coughing for 47 respiratory episodes. Thirty hospitalizations were avoided. Seventy-five percent of the patients were extremely satisfied. Mean monthly cost per patient for on-demand telephone consultation, professional home healthcare visits, and MI-E as deemed necessary was euro403 +/- euro420 or 59% less than for continuous MI-E rental. Hospitalization costs were also spared.
CONCLUSIONS: An on-demand consult and MI-E access program can avoid hospitalizations for patients with amyotrophic lateral sclerosis with significant cost savings.

Entities:  

Mesh:

Year:  2010        PMID: 20407305     DOI: 10.1097/PHM.0b013e3181d89760

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  7 in total

Review 1.  Economic Studies in Motor Neurone Disease: A Systematic Methodological Review.

Authors:  Alan Moore; Carolyn A Young; Dyfrig A Hughes
Journal:  Pharmacoeconomics       Date:  2017-04       Impact factor: 4.981

2.  Comparison of Mechanical Insufflation-Exsufflation and Endotracheal Suctioning in Mechanically Ventilated Patients: Effects on Respiratory Mechanics, Hemodynamics, and Volume of Secretions.

Authors:  William M Coutinho; Paulo J C Vieira; Fernanda M Kutchak; Alexandre S Dias; Marcelo M Rieder; Luiz Alberto Forgiarini
Journal:  Indian J Crit Care Med       Date:  2018-07

Review 3.  New technologies and Amyotrophic Lateral Sclerosis - Which step forward rushed by the COVID-19 pandemic?

Authors:  Susana Pinto; Stefano Quintarelli; Vincenzo Silani
Journal:  J Neurol Sci       Date:  2020-08-05       Impact factor: 3.181

4.  Management of respiratory complications and rehabilitation in individuals with muscular dystrophies: 1st Consensus Conference report from UILDM - Italian Muscular Dystrophy Association (Milan, January 25-26, 2019).

Authors:  Fabrizio Rao; Giancarlo Garuti; Michele Vitacca; Paolo Banfi; Fabrizio Racca; Renato Cutrera; Martino Pavone; Marina Pedemonte; Matteo Schisano; Stefania Pedroni; Jacopo Casiraghi; Andrea Vianello; Valeria A Sansone
Journal:  Acta Myol       Date:  2021-03-31

Review 5.  A Review on Cough Augmentation Techniques: Assisted Inspiration, Assisted Expiration and Their Combination.

Authors:  A Spinou
Journal:  Physiol Res       Date:  2020-03-27       Impact factor: 1.881

Review 6.  Sleep and Sleep Disruption in Amyotrophic Lateral Sclerosis.

Authors:  Matthias Boentert
Journal:  Curr Neurol Neurosci Rep       Date:  2020-05-27       Impact factor: 5.081

Review 7.  Telemedicine in the management of patients with chronic respiratory failure.

Authors:  Neeraj M Shah; Georgios Kaltsakas
Journal:  Breathe (Sheff)       Date:  2021-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.